Survival of adult AML patients treated with chemotherapy in the U.S. population by age, race and ethnicity, sex, calendar-year period, and AML subgroup, 2001–2019Research in context
Summary: Background: Population-based survival studies of adult acute myeloid leukemia (AML) have not simultaneously evaluated age at diagnosis, race and ethnicity, sex, calendar period or AML subtypes/subgroups among chemotherapy-treated patients. Methods: For 28,473 chemotherapy-treated AML patie...
Main Authors: | Martha S. Linet, Rochelle E. Curtis, Sara J. Schonfeld, Jacqueline B. Vo, Lindsay M. Morton, Graça M. Dores |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-05-01
|
Series: | EClinicalMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537024001287 |
Similar Items
-
CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML
by: Matteo Molica, et al.
Published: (2022-06-01) -
Acute Myeloid Leukemia (AML): The Role of Maintenance Chemo-therapy
by: Thomas Büchner, et al.
Published: (2004-03-01) -
Increasing Role of Targeted Immunotherapies in the Treatment of AML
by: Jochen Greiner, et al.
Published: (2022-03-01) -
Transformation of CMML to AML presenting with acute kidney injury
by: Rebecca DeBoer, et al.
Published: (2020-07-01) -
Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG
by: Mareike Rasche, et al.
Published: (2021-05-01)